To treat HIV infections, the drug categories used are integrase inhibitors, protease inhibitors, reverse transcriptase inhibitors, and fusion inhibitors. DNase inhibitors are not used in HIV treatment.
The drug categories used to treat HIV infections include integrase inhibitors, protease inhibitors, and reverse transcriptase inhibitors. Integrase inhibitors, such as raltegravir, block the incorporation of viral DNA into the host cell chromosome. Protease inhibitors, like ritonavir, impede the processing of HIV proteins, preventing the maturation of the virus.
Reverse transcriptase inhibitors target the conversion of HIV's RNA into DNA, with examples like AZT (zidovudine). However, DNase inhibitors are not used for HIV treatment as HIV does not utilize DNA in its early replicative cycle.
In conclusion, the correct drug classes used to treat HIV are integrase inhibitors, protease inhibitors, reverse transcriptase inhibitors, and fusion inhibitors. The combination of these drugs, referred to as a 'cocktail', is the most effective strategy to manage HIV due to its ability to rapidly mutate and develop resistance. DNase inhibitors are not relevant in the context of HIV treatment.